You just read:

Titan Pharmaceuticals And Braeburn Announce Mutual Termination Of License Agreement For Probuphine® For Opioid Dependence

News provided by

Titan Pharmaceuticals, Inc.; Braeburn

May 30, 2018, 07:00 ET